Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Direct to consumer genetic testing: Avoiding a culture war.

Literature DB >> 19606051

Direct to consumer genetic testing: Avoiding a culture war.

James P Evans¹, Robert C Green.

Abstract

Entities: Chemical

Mesh：

Year: 2009 PMID： 19606051 PMCID： PMC2920210 DOI： 10.1097/GIM.0b013e3181afbaed

Source DB: PubMed Journal: Genet Med ISSN： 1098-3600 Impact factor: 8.822

× No keyword cloud information.

11 in total

Review 1. Clinical versus actuarial judgment.

Authors: R M Dawes; D Faust; P E Meehl
Journal: Science Date: 1989-03-31 Impact factor: 47.728

2. Oversight of US genetic testing laboratories.

Authors: Kathy L Hudson; Juli A Murphy; David J Kaufman; Gail H Javitt; Sara H Katsanis; Joan Scott
Journal: Nat Biotechnol Date: 2006-09 Impact factor: 54.908

3. ASHG Statement* on direct-to-consumer genetic testing in the United States.

Authors: Kathy Hudson; Gail Javitt; Wylie Burke; Peter Byers
Journal: Obstet Gynecol Date: 2007-12 Impact factor: 7.661

4. Genetic risk prediction--are we there yet?

Authors: Peter Kraft; David J Hunter
Journal: N Engl J Med Date: 2009-04-15 Impact factor: 91.245

5. Shattuck lecture--clinical research to clinical practice--lost in translation?

Authors: Claude Lenfant
Journal: N Engl J Med Date: 2003-08-28 Impact factor: 91.245

6. Screening and prostate-cancer mortality in a randomized European study.

Authors: Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal: N Engl J Med Date: 2009-03-18 Impact factor: 91.245

7. Mortality results from a randomized prostate-cancer screening trial.

Authors: Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal: N Engl J Med Date: 2009-03-18 Impact factor: 91.245

8. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal: JAMA Date: 2002-07-17 Impact factor: 56.272

9. An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons.

Authors: Amy L McGuire; Wylie Burke
Journal: JAMA Date: 2008-12-10 Impact factor: 56.272

10. Genotype score in addition to common risk factors for prediction of type 2 diabetes.

Authors: James B Meigs; Peter Shrader; Lisa M Sullivan; Jarred B McAteer; Caroline S Fox; Josée Dupuis; Alisa K Manning; Jose C Florez; Peter W F Wilson; Ralph B D'Agostino; L Adrienne Cupples
Journal: N Engl J Med Date: 2008-11-20 Impact factor: 91.245

33 in total

1. Research ethics in the era of personalized medicine: updating science's contract with society.

Authors: Eric M Meslin; Mildred K Cho
Journal: Public Health Genomics Date: 2010-08-31 Impact factor: 2.000

2. Inferring genetic ancestry: opportunities, challenges, and implications.

Authors: Charmaine D Royal; John Novembre; Stephanie M Fullerton; David B Goldstein; Jeffrey C Long; Michael J Bamshad; Andrew G Clark
Journal: Am J Hum Genet Date: 2010-05-14 Impact factor: 11.025

3. Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing.

Authors: David J Kaufman; Juli M Bollinger; Rachel L Dvoskin; Joan A Scott
Journal: J Genet Couns Date: 2012-01-26 Impact factor: 2.537

4. Health-care referrals from direct-to-consumer genetic testing.

Authors: Monica A Giovanni; Matthew R Fickie; Lisa S Lehmann; Robert C Green; Lisa M Meckley; David Veenstra; Michael F Murray
Journal: Genet Test Mol Biomarkers Date: 2010-10-28

5. Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?

Authors: Caroline Fiona Wright; Mark Kroese
Journal: Hum Genet Date: 2009-11-20 Impact factor: 4.132

Review 6. The future of direct-to-consumer clinical genetic tests.

Authors: Felix W Frueh; Henry T Greely; Robert C Green; Stuart Hogarth; Sue Siegel
Journal: Nat Rev Genet Date: 2011-06-01 Impact factor: 53.242

7. Primary care physicians' awareness, experience and opinions of direct-to-consumer genetic testing.

Authors: Karen P Powell; Whitney A Cogswell; Carol A Christianson; Gaurav Dave; Amit Verma; Sonja Eubanks; Vincent C Henrich
Journal: J Genet Couns Date: 2011-07-16 Impact factor: 2.537

8. Third-Party Genetic Interpretation Tools: A Mixed-Methods Study of Consumer Motivation and Behavior.

Authors: Sarah C Nelson; Deborah J Bowen; Stephanie M Fullerton
Journal: Am J Hum Genet Date: 2019-06-13 Impact factor: 11.025

9. Consumer Perspectives on Access to Direct-to-Consumer Genetic Testing: Role of Demographic Factors and the Testing Experience.

Authors: Sarah E Gollust; Stacy W Gray; Deanna Alexis Carere; Barbara A Koenig; Lisa Soleymani Lehmann; Amy L McGUIRE; Richard R Sharp; Kayte Spector-Bagdady; N A Wang; Robert C Green; J Scott Roberts
Journal: Milbank Q Date: 2017-06 Impact factor: 4.911

10. Management of incidental findings in clinical genomic sequencing.

Authors: Joel B Krier; Robert C Green
Journal: Curr Protoc Hum Genet Date: 2013